LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device

FDA 510(k) K182698 · DiaSorin, Inc.

Substantially Equivalent

510(k) numberK182698

Submission

Device name
LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device
Applicant
DiaSorin, Inc.
Stillwater, MN, US
Received
September 27, 2018
Decision date
December 26, 2018
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
NXO – Calprotectin, Fecal
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5180
Specialty
Immunology

The device is used for the measurement, in human stool, of fecal calprotectin, a neutrophilic protein that is a marker of mucosal inflammation. The device can be used as an aid in the diagnosis of inflammatory bowel disease (ibd), crohn's disease and ulcerative colitis and to differentiate ibd from irritable bowel syndrome.

Other 510(k)s with product code NXO

510(k)DeviceApplicantDecision
K232057BÜHLMANN fCAL® turbo and CALEX® CapNXO · Special Bühlmann Laboratories AG02/06/2024SE
K220763ALPCO Calprotectin Immunoturbidimetric AssayNXO · Traditional Alpco04/13/2023SE
K213858LIAISON Calprotectin, LIAISON Q.S.E.T. Device PlusNXO · Traditional DiaSorin, Inc.07/26/2022SE
K191807ALPCO Calprotectin Chemiluminescence ELISA, ALPCO Easy Stool Extraction DeviceNXO · Traditional Alpco10/25/2019SE
K191718Buhlmann fCAL turbo and CALEX CapNXO · Traditional Buhlmann Laboratories AG09/24/2019SE
K191592CalprestNG, EasyCalNXO · Special Eurospital S.P.A.07/10/2019SE
K191589Calprest, EasyCalNXO · Special Eurospital S.P.A.07/10/2019SE
K190784BUHLMANN fCAL turboNXO · Traditional Buhlmann Laboratories AG06/25/2019SE
K180971QUANTA Flash Calprotectin and Fecal Extraction DeviceNXO · Traditional Inova Diagnostics, Inc.10/16/2018SE
K181012BUHLMANN fCAL ELISANXO · Traditional Buhlmann Laboratories AG06/04/2018SE

More from Buhlmann Laboratories AG

510(k)DeviceDecision
K260770LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteXLOM · Traditional 06/04/2026SE
K231214LIAISON VZV IgG HT, LIAISON Control VZV IgG HTLFY · Traditional 10/27/2023SE
K223403LIAISON Anti-HAV; LIAISON XSLOL · Special 12/09/2022SE
K213858LIAISON Calprotectin, LIAISON Q.S.E.T. Device PlusNXO · Traditional 07/26/2022SE
K213936LIAISON MeMed BV, LIAISON MeMed BV Control SetQPS · Traditional 07/14/2022SE
K193650LIAISON FerritinDBF · Traditional 09/14/2021SE
K202574LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody PlusLSR · Traditional 02/18/2021SE
K202573LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody PlusLSR · Traditional 02/18/2021SE
K210272LIAISON Anti-HAVLOL · Special 02/09/2021SE
K201908LIAISON Testosterone xtCDZ · Special 10/15/2020SE

Questions and answers

When was LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device cleared by the FDA?

LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device (K182698) received a 510(k) decision of Substantially Equivalent on December 26, 2018, 90 days after the submission was received.

What is the product code of K182698?

The FDA product code is NXO – Calprotectin, Fecal, a Class II (moderate risk) device regulated under 21 CFR 866.5180.